KLC Advises Teva on Greek Manufacturing Site Divestment to PharmaPath
eKapija | Teva acquires Actavis for USD 33.43 billion and 100 million shares – Modern pharmaceutical drugs and therapies more available to clients in Serbia
Teva Pharmaceuticals to sell Serbian unit Zdravlje